Mexico watchdog finds big pharma faces no competition on some drugs

MEXICO CITY (Reuters) – Major drugmakers including GlaxoSmithKline Plc and Pfizer Inc face no competition in Mexico from generics that are readily available elsewhere, partly because of regulatory failings, Mexico’s antitrust body said on Wednesday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply